You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obstructive hypertrophic cardiomyopathy

Showing 1 - 25 of 7,165
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mavacamten in Korean Symptomatic Obstructive Hypertrophic

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Nov 23, 2023

Obstructive Hypertrophic Cardiomyopathy Trial (HRS-1893, Placebo)

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • (no location specified)
May 18, 2023

Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on

Active, not recruiting
  • Hypertrophic Cardiomyopathy
  • Arrhythmia
  • Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
  • Xi'an, Shaanxi, China
    Ultrasound Medicine Department of Xijing Hospital, Fourth Milita
Sep 4, 2023

Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)

Recruiting
  • Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
  • Anchorage, Alaska
  • +1 more
Oct 12, 2023

Obstructive Hypertrophic Cardiomyopathy Trial in Milan (pace maker implant guided by acute hemodynamic testing)

Recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • pace maker implant guided by acute hemodynamic testing
  • Milan, Italy
    Istituto Auxologico Italiano
Mar 6, 2023

Obstructive Hypertrophic Cardiomyopathy

Completed
  • Microvascular Dysfunction
  • +2 more
    • Beijing, Beijing, China
      Fuwai Hospital, China National Center for Cardiovascular Disease
    Jan 11, 2023

    Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive

    Completed
    • Septal Hypertrophy
    • Obstructive Hypertrophic Cardiomyopathy
    • Cryo myectomy
    • Myectomy
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Feb 3, 2023

    Obstructive Hypertrophic Cardiomyopathy Trial in Boston, Kansas City, Omaha

    Not yet recruiting
    • Obstructive Hypertrophic Cardiomyopathy
      • (no location specified)
      Aug 3, 2022

      Hypertrophic Cardiomyopathy Trial in San Francisco (Moderate Intensity Exercise Program)

      Recruiting
      • Hypertrophic Cardiomyopathy
      • Moderate Intensity Exercise Program
      • San Francisco, California
        University of California - San Francisco
      Apr 5, 2023

      Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

      Not yet recruiting
      • Obstructive Hypertrophic Cardiomyopathy (oHCM)
      • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
      • +3 more
      • (no location specified)
      Mar 2, 2023

      Cardiomyopathy, Hypertrophic Trial in Worldwide (Mavacamten, Placebo)

      Not yet recruiting
      • Cardiomyopathy, Hypertrophic
      • West Hollywood, California
      • +9 more
      Oct 27, 2023

      Patients' Long-Term Survival of Obstructive Hypertrophic

      Completed
      • Cardiomyopathy
      • Obstructive Hypertrophic Cardiomyopathy
        • Bethesda, Maryland
          National Heart, Lung and Blood Institute (NHLBI)
        May 27, 2022

        Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

        Not yet recruiting
        • Obstructive Hypertrophic Cardiomyopathy
        • Charlottesville, Virginia
          University of Virginia
        Aug 28, 2023

        Non-obstructive Hypertrophic Cardiomyopathy Trial in Denmark (Verapamil, Bisoprolol, Placebo)

        Recruiting
        • Non-obstructive Hypertrophic Cardiomyopathy
        • Aarhus N, Denmark
        • +6 more
        Dec 5, 2022

        Obstructive Hypertrophic Cardiomyopathy Trial in China (Aficamten)

        Not yet recruiting
        • Obstructive Hypertrophic Cardiomyopathy
        • Beijing, China
        • +9 more
        Oct 31, 2023

        Cardiomyopathy, Hypertrophic Trial in Bologna, Alicante/alacant (MYK-224)

        Not yet recruiting
        • Cardiomyopathy, Hypertrophic
        • Bologna, BO, Italy
        • +1 more
        Sep 23, 2022

        Hypertrophic Cardiomyopathy Trial in United States (mavacamten)

        Active, not recruiting
        • Hypertrophic Cardiomyopathy
        • Scottsdale, Arizona
        • +3 more
        Jun 10, 2022

        Non-obstructive Hypertrophic Cardiomyopathy Trial in United Kingdom, United States (IMB-1018972, Placebo)

        Recruiting
        • Non-obstructive Hypertrophic Cardiomyopathy
        • La Jolla, California
        • +13 more
        Oct 11, 2022

        Cardiomyopathy, Hypertrophic Obstructive Trial in Chuo-Ku (Mavacamten)

        Recruiting
        • Cardiomyopathy, Hypertrophic Obstructive
        • Uwajima, Ehime, Japan
        • +18 more
        Jan 20, 2023

        Functional Capacity and Quality of Life Following Septal

        Recruiting
        • Hypertrophic Cardiomyopathy
          • Cleveland, Ohio
            Cleveland Clinic
          May 3, 2022

          Hypertrophic Obstructive Cardiomyopathy Trial in Wuhan (Transapical beating-heart septal myectomy)

          Recruiting
          • Hypertrophic Obstructive Cardiomyopathy
          • Transapical beating-heart septal myectomy
          • Wuhan, Hubei, China
            Tongji Hospital, Tongji Medical College, Huazhong University of
          Jul 14, 2023

          Influencing Factors of Liwen Procedure in The Treatment of

          Active, not recruiting
          • Hypertrophic Obstructive Cardiomyopathy
          • Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
          • Xi'an, Shaanxi, China
            Ultrasound Medicine Department of Xijing Hospital, Fourth Milita
          Aug 20, 2023

          Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy:

          Completed
          • Hypertrophic Obstructive Cardiomyopathy
          • Mitral Regurgitation
          • Septal myectomy and mitral valve repair with edge-to-edge technique
          • Milan, Italy
            IRCCS Ospedale San Raffaele
          Apr 28, 2023

          Hypertrophic Obstructive Cardiomyopathy Trial

          Completed
          • Hypertrophic Obstructive Cardiomyopathy
            • (no location specified)
            Jan 13, 2023

            Hypertrophic Obstructive Cardiomyopathy Trial in Wuhan (Minimally invasive transapical septal myectomy for Hypertrophic

            Recruiting
            • Hypertrophic Obstructive Cardiomyopathy
            • Transapical beating-heart septal myectomy
            • Wuhan, Hubei, China
              Tongji Hospital, Tongji Medical College, Huazhong University of
            Dec 4, 2022